SCHEMBL6597830

SCHEMBL6597830

OCc1ncc2ccccc2n1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SORD Q00796 6/20 0.47
KDM4E B2RXH2 2/20 0.42
GPR3 P46089 1/20 0.42
EGFR P00533 1/20 0.42
CYP1A2 P05177 2/20 0.40
ALDH1A1 P00352 4/20 0.39
GLA P06280 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ACHE P22303 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
HTR3A P46098 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
FDPS P14324 1/20 0.38
PDE10A Q9Y233 2/20 0.38
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL28289229 0.89 SORD (0.44) SORDKDM4EGPR3EGFRCYP1A2
SCHEMBL7074398 0.81 KDM4E (0.37) SORDKDM4EGPR3EGFRCYP1A2
SCHEMBL290894 0.79 KDM4E (0.42) KDM4EGPR3EGFRCYP1A2ALDH1A1
SCHEMBL29756554 0.79 KMT2A (0.44) KDM4EGPR3EGFRCYP1A2ALDH1A1
SCHEMBL30838793 0.79 CYP1A2 (0.42) KDM4EGPR3EGFRCYP1A2ALDH1A1
SCHEMBL874900 0.79 KMT2A (0.44) KDM4EGPR3EGFRCYP1A2ALDH1A1
SCHEMBL9934866 0.79 KDM4E (0.42) KDM4EGPR3EGFRCYP1A2ALDH1A1
SCHEMBL9971234 0.79 KDM4E (0.42) KDM4EGPR3EGFRCYP1A2ALDH1A1
SCHEMBL1514912 0.79 CYP1A2 (0.42) KDM4EGPR3EGFRCYP1A2ALDH1A1
SCHEMBL2263641 0.79 KDM4E (0.42) KDM4EGPR3EGFRCYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110028491-A Fibroblast growth factor receptor inhibitor 蓝图药品公司 2019-07-19 CN disclosed
CN-106852143-B Tricyclic triazolic compounds 埃斯蒂维制药股份公司 2019-07-16 CN disclosed
CN-105658642-B Fibroblast growth factor receptor inhibitors 蓝图药品公司 2019-05-03 CN disclosed
CN-109705094-A A kind of preparation method of pyridine quinazoline 湖南速博生物技术有限公司 2019-05-03 CN disclosed
CN-109526220-A Tetrahydropyrimidinodiazepine and tetrahydropyridodiazepine compounds for the treatment of pain and pain-related conditions 埃斯特维制药股份公司 2019-03-26 CN disclosed
CN-106432252-B A kind of benzo carbazole derivative and the organic electroluminescence device using the derivative 上海和辉光电有限公司 2018-11-30 CN disclosed
CN-105218476-B A kind of preparation method for treating lung-cancer medicament 上海天慈生物谷生物工程有限公司 2018-03-13 CN disclosed
CN-107750404-A The Organic Light Emitting Diode of different substrates compound is included in the first and second electron transfer layers 诺瓦尔德股份有限公司 2018-03-02 CN disclosed
CN-105418516-B A kind of quinazoline compounds and preparation method thereof 信阳师范学院 2018-03-02 CN disclosed
CN-107210374-A Include the Organic Light Emitting Diode of the electron transfer layer with different substrates compound 诺瓦尔德股份有限公司 2017-09-26 CN disclosed
CN-106852143-A Tricyclic triazolic compounds 埃斯蒂维实验室股份有限公司 2017-06-13 CN disclosed
CN-102459249-A Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases EXELIXIS INC 2012-05-16 CN disclosed
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed